Cadila Healthcare Q1 profit over threefold to Rs 460 cr

The company had reported a net profit of Rs 138.4 crore in the year-ago period, Cadila Healthcare said in a BSE filing.

Cadila Healthcare today reported over three-fold jump in consolidated net profit to Rs 460.5 crore for the quarter ended June 30, 2018, on account of robust sales.

The company had reported a net profit of Rs 138.4 crore in the year-ago period, Cadila Healthcare said in a BSE filing.

Total revenue from operations stood at Rs 2,893.7 crore for the reported quarter. It was Rs 2,234.8 crore in the same period a year ago.

"The company's business in the US posted sales of Rs 1,230 crore, up 27 percent," it said.

During the quarter, the company launched 9 new products in the US. It filed 3 additional abbreviated new drug applications (ANDAs) with the US health regulator and received 13 ANDA approvals during the quarter.

"The India formulations business posted sales of Rs 893 crore, up 40 percent," the company said.

Shares of Cadila Healthcare were trading at Rs 354.80 per scrip on BSE, down 5.76 percent from its previous close.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)